153 related articles for article (PubMed ID: 29458616)
21. Bacterial cellulose hydrogel loaded with lipid nanoparticles for localized cancer treatment.
Cacicedo ML; Islan GA; León IE; Álvarez VA; Chourpa I; Allard-Vannier E; García-Aranda N; Díaz-Riascos ZV; Fernández Y; Schwartz S; Abasolo I; Castro GR
Colloids Surf B Biointerfaces; 2018 Oct; 170():596-608. PubMed ID: 29975908
[TBL] [Abstract][Full Text] [Related]
22. pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells.
Chen HH; Huang WC; Chiang WH; Liu TI; Shen MY; Hsu YH; Lin SC; Chiu HC
Int J Nanomedicine; 2015; 10():5035-48. PubMed ID: 26346762
[TBL] [Abstract][Full Text] [Related]
23. Modification of oral absorption of oxyresveratrol using lipid based nanoparticles.
Sangsen Y; Wiwattanawongsa K; Likhitwitayawuid K; Sritularak B; Wiwattanapatapee R
Colloids Surf B Biointerfaces; 2015 Jul; 131():182-90. PubMed ID: 25988282
[TBL] [Abstract][Full Text] [Related]
24. Formulation optimization, characterization, and evaluation of in vitro cytotoxic potential of curcumin loaded solid lipid nanoparticles for improved anticancer activity.
Rompicharla SVK; Bhatt H; Shah A; Komanduri N; Vijayasarathy D; Ghosh B; Biswas S
Chem Phys Lipids; 2017 Nov; 208():10-18. PubMed ID: 28842128
[TBL] [Abstract][Full Text] [Related]
25. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
[TBL] [Abstract][Full Text] [Related]
26. Electrospray fabrication of doxorubicin-chitosan-tripolyphosphate nanoparticles for delivery of doxorubicin.
Songsurang K; Praphairaksit N; Siraleartmukul K; Muangsin N
Arch Pharm Res; 2011 Apr; 34(4):583-92. PubMed ID: 21544723
[TBL] [Abstract][Full Text] [Related]
27. Investigation of novel superparamagnetic Ni
Qasim M; Asghar K; Dharmapuri G; Das D
Nanotechnology; 2017 Sep; 28(36):365101. PubMed ID: 28675377
[TBL] [Abstract][Full Text] [Related]
28. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin.
Subedi RK; Kang KW; Choi HK
Eur J Pharm Sci; 2009 Jun; 37(3-4):508-13. PubMed ID: 19406231
[TBL] [Abstract][Full Text] [Related]
29. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
[TBL] [Abstract][Full Text] [Related]
30. Physicochemical characterization of sildenafil-loaded solid lipid nanoparticle dispersions (SLN) for pulmonary application.
Paranjpe M; Finke JH; Richter C; Gothsch T; Kwade A; Büttgenbach S; Müller-Goymann CC
Int J Pharm; 2014 Dec; 476(1-2):41-9. PubMed ID: 25261709
[TBL] [Abstract][Full Text] [Related]
31. Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity.
Zhang L; Zhu K; Zeng H; Zhang J; Pu Y; Wang Z; Zhang T; Wang B
Int J Nanomedicine; 2019; 14():6061-6071. PubMed ID: 31534336
[No Abstract] [Full Text] [Related]
32. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP
J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859
[TBL] [Abstract][Full Text] [Related]
33. Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro/in vivo evaluation.
Scioli Montoto S; Sbaraglini ML; Talevi A; Couyoupetrou M; Di Ianni M; Pesce GO; Alvarez VA; Bruno-Blanch LE; Castro GR; Ruiz ME; Islan GA
Colloids Surf B Biointerfaces; 2018 Jul; 167():73-81. PubMed ID: 29627680
[TBL] [Abstract][Full Text] [Related]
34. Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles.
Akanda MH; Rai R; Slipper IJ; Chowdhry BZ; Lamprou D; Getti G; Douroumis D
Int J Pharm; 2015 Sep; 493(1-2):161-71. PubMed ID: 26200751
[TBL] [Abstract][Full Text] [Related]
35. Doxorubicin Loaded Silica Nanoparticles with Dual Modification as a Tumor-Targeted Drug Delivery System for Colon Cancer Therapy.
Lin YQ; Zhang J; Liu SJ; Ye H
J Nanosci Nanotechnol; 2018 Apr; 18(4):2330-2336. PubMed ID: 29442900
[TBL] [Abstract][Full Text] [Related]
36. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
Attama AA; Müller-Goymann CC
Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
[TBL] [Abstract][Full Text] [Related]
37. [Microstructure of novel solid lipid nanoparticle loaded triptolide].
Hou DZ; Xie CS; Yang XL; Xu HB; Ping QN
Yao Xue Xue Bao; 2007 Apr; 42(4):429-33. PubMed ID: 17633214
[TBL] [Abstract][Full Text] [Related]
38. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
39. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
Wong HL; Rauth AM; Bendayan R; Wu XY
Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer targeted chemotherapy based on doxorubicin-loaded bombesin peptide modified nanocarriers.
Wang C; Sun X; Wang K; Wang Y; Yang F; Wang H
Drug Deliv; 2016 Oct; 23(8):2697-2702. PubMed ID: 26203692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
